Trial Outcomes & Findings for Fasting Versus Fed: Effect of Oral Intake Prior to the Glucose Tolerance Test in Pregnancy (NCT NCT04547023)
NCT ID: NCT04547023
Last Updated: 2022-11-21
Results Overview
Number of positive GDM screen (\>= 140 mg/dL) on the 1 hour 50-g oral glucose tolerance test conducted between 24-28 weeks gestation This outcome was assessed in pregnant participants.
COMPLETED
NA
200 participants
Day of GDM screen (occurring between 24-28 weeks gestation)
2022-11-21
Participant Flow
This study enrolled pregnant participants. While outcomes were assessed in neonates, they were not considered to be enrolled.
Participant milestones
| Measure |
Fasting Before Gestational Diabetes Screen
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
|
Fed Before Gestational Diabetes Screen
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
|
|---|---|---|
|
Overall Study
STARTED
|
100
|
100
|
|
Overall Study
COMPLETED
|
96
|
97
|
|
Overall Study
NOT COMPLETED
|
4
|
3
|
Reasons for withdrawal
| Measure |
Fasting Before Gestational Diabetes Screen
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
|
Fed Before Gestational Diabetes Screen
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
|
|---|---|---|
|
Overall Study
Did Not Receive Intervention
|
3
|
2
|
|
Overall Study
Lost to Follow-up
|
1
|
1
|
Baseline Characteristics
Fasting Versus Fed: Effect of Oral Intake Prior to the Glucose Tolerance Test in Pregnancy
Baseline characteristics by cohort
| Measure |
Fasting Before Gestational Diabetes Screen
n=100 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
|
Fed Before Gestational Diabetes Screen
n=100 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
|
Total
n=200 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
32.2 years
STANDARD_DEVIATION 4.2 • n=5 Participants
|
33.2 years
STANDARD_DEVIATION 4.7 • n=7 Participants
|
32.7 years
STANDARD_DEVIATION 4.5 • n=5 Participants
|
|
Sex: Female, Male
Female
|
100 Participants
n=5 Participants
|
100 Participants
n=7 Participants
|
200 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Asian/ Pacific Islander
|
39 Participants
n=5 Participants
|
35 Participants
n=7 Participants
|
74 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Hispanic
|
6 Participants
n=5 Participants
|
17 Participants
n=7 Participants
|
23 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Non-Hispanic Black
|
2 Participants
n=5 Participants
|
3 Participants
n=7 Participants
|
5 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Non-Hispanic White
|
49 Participants
n=5 Participants
|
40 Participants
n=7 Participants
|
89 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Other
|
4 Participants
n=5 Participants
|
5 Participants
n=7 Participants
|
9 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
100 Participants
n=5 Participants
|
100 Participants
n=7 Participants
|
200 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: Day of GDM screen (occurring between 24-28 weeks gestation)Population: Participants who completed the 1 hour GDM screen are included in the analysis
Number of positive GDM screen (\>= 140 mg/dL) on the 1 hour 50-g oral glucose tolerance test conducted between 24-28 weeks gestation This outcome was assessed in pregnant participants.
Outcome measures
| Measure |
Fasting Before Gestational Diabetes Screen
n=97 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
|
Fed Before Gestational Diabetes Screen
n=98 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
|
|---|---|---|
|
Number of Participants With a Positive Gestational Diabetes Mellitus (GDM) Screen (>= 140 mg/dL) on the 1 Hour 50-g Oral Glucose Tolerance Test (OGTT)
|
31 Participants
|
13 Participants
|
SECONDARY outcome
Timeframe: Day of GDM screen (occurring between 24-28 weeks gestation)Population: Participants who completed the 1 hour GDM screen are included in the analysis
Outcome measures
| Measure |
Fasting Before Gestational Diabetes Screen
n=97 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
|
Fed Before Gestational Diabetes Screen
n=98 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
|
|---|---|---|
|
Mean Gestational Age at OGTT Screen
|
25.7 weeks
Standard Deviation 1.2
|
25.8 weeks
Standard Deviation 1.3
|
SECONDARY outcome
Timeframe: Day of GDM screen (occurring between 24-28 weeks gestation)Population: Participants who completed the 1 hour GDM screen are included in the analysis
Outcome measures
| Measure |
Fasting Before Gestational Diabetes Screen
n=97 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
|
Fed Before Gestational Diabetes Screen
n=98 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
|
|---|---|---|
|
Mean Glucose Level at the OGTT Screen
|
127.7 mg/dL
Standard Deviation 35.8
|
113.3 mg/dL
Standard Deviation 26.4
|
SECONDARY outcome
Timeframe: Day of GDM screen (occurring between 24-28 weeks gestation)Population: Participants who completed the 1 hour GDM screen are included in the analysis
This outcome was assessed in pregnant participants.
Outcome measures
| Measure |
Fasting Before Gestational Diabetes Screen
n=97 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
|
Fed Before Gestational Diabetes Screen
n=98 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
|
|---|---|---|
|
Number of Participants With Positive GDM Diagnosis Based on the OGTT
|
8 Participants
|
2 Participants
|
SECONDARY outcome
Timeframe: Day of GDM screen (occurring between 24-28 weeks gestation)Population: Participants who completed the 1 hour GDM screen are included in the analysis
Average number of hours since the participant's last oral intake prior to OGTT screen
Outcome measures
| Measure |
Fasting Before Gestational Diabetes Screen
n=97 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
|
Fed Before Gestational Diabetes Screen
n=98 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
|
|---|---|---|
|
Average Time of Last Oral Intake Prior to the OGTT Screen
|
10.7 hours
Standard Deviation 3.0
|
1.4 hours
Standard Deviation 0.9
|
SECONDARY outcome
Timeframe: Day of OGTT (occurring at 24-28 weeks gestation up to 42 weeks gestation)Population: Participants who completed the 1 hour GDM screen are included in the analysis
GDM diagnosis based on 1-hour OGTT ≥ 180 mg/dL or 2 elevated values on the 3-hour OGTT using Carpenter and Coustan criteria. This outcome was assessed in pregnant participants Carpenter and Coustan Criteria is as follows (if 2 or more values are elevated, this is gestational diabetes): * Fasting glucose \< 95; * One hour glucose \< 180; * Two hour glucose \< 155; * Three hour glucose \< 140
Outcome measures
| Measure |
Fasting Before Gestational Diabetes Screen
n=97 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
|
Fed Before Gestational Diabetes Screen
n=98 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
|
|---|---|---|
|
Number of Participants With Positive GDM Diagnosis
|
12 Participants
|
5 Participants
|
SECONDARY outcome
Timeframe: At time of delivery (Up to 42 weeks' gestation)Population: Participants who had delivery data are included in the analysis.
Outcome measures
| Measure |
Fasting Before Gestational Diabetes Screen
n=96 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
|
Fed Before Gestational Diabetes Screen
n=96 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
|
|---|---|---|
|
Mean Gestational Age at Delivery
|
272 days
Standard Deviation 12
|
272 days
Standard Deviation 10
|
SECONDARY outcome
Timeframe: At time of delivery (up to 42 weeks' gestation)Population: Participants who had delivery data are included in the analysis.
This outcome was assessed in pregnant participants.
Outcome measures
| Measure |
Fasting Before Gestational Diabetes Screen
n=96 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
|
Fed Before Gestational Diabetes Screen
n=96 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
|
|---|---|---|
|
Number of Participants Who Delivered Vaginally
|
67 Participants
|
53 Participants
|
SECONDARY outcome
Timeframe: At time of delivery (up to 42 weeks' gestation)Population: Participants who had delivery data are included in the analysis.
This outcome was assessed in pregnant participants.
Outcome measures
| Measure |
Fasting Before Gestational Diabetes Screen
n=96 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
|
Fed Before Gestational Diabetes Screen
n=96 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
|
|---|---|---|
|
Number of Participants Who Delivered Via Operative Vaginal Birth
|
3 Participants
|
7 Participants
|
SECONDARY outcome
Timeframe: At time of delivery (up to 42 weeks' gestation)Population: Participants who had delivery data are included in the analysis.
This outcome was assessed in pregnant participants.
Outcome measures
| Measure |
Fasting Before Gestational Diabetes Screen
n=96 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
|
Fed Before Gestational Diabetes Screen
n=96 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
|
|---|---|---|
|
Number of Participants Who Delivered Vaginally After a Prior Cesarean Section
|
2 Participants
|
1 Participants
|
SECONDARY outcome
Timeframe: At time of delivery (up to 42 weeks' gestation)Population: Participants who had delivery data are included in the analysis.
Primary = first Cesarean section for participant. This outcome was assessed in pregnant participants.
Outcome measures
| Measure |
Fasting Before Gestational Diabetes Screen
n=96 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
|
Fed Before Gestational Diabetes Screen
n=96 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
|
|---|---|---|
|
Number of Participants Who Delivered Via a Primary Cesarean Section
|
17 Participants
|
21 Participants
|
SECONDARY outcome
Timeframe: At time of delivery (up to 42 weeks' gestation)Population: Participants who had delivery data are included in the analysis.
This outcome was assessed in pregnant participants.
Outcome measures
| Measure |
Fasting Before Gestational Diabetes Screen
n=96 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
|
Fed Before Gestational Diabetes Screen
n=96 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
|
|---|---|---|
|
Number of Participants Who Delivered Via a Repeat Cesarean Section
|
7 Participants
|
14 Participants
|
SECONDARY outcome
Timeframe: At time of delivery (up to 42 weeks' gestation)Population: Participants who had delivery data are included in the analysis.
Shoulder dystocia is a birth injury (also called birth trauma) that happens when one or both of a baby's shoulders get stuck inside the mother's pelvis during labor and birth. This outcome was assessed in pregnant participants.
Outcome measures
| Measure |
Fasting Before Gestational Diabetes Screen
n=96 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
|
Fed Before Gestational Diabetes Screen
n=96 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
|
|---|---|---|
|
Number of Participants Complicated by Shoulder Dystocia at Delivery
|
0 Participants
|
1 Participants
|
SECONDARY outcome
Timeframe: At time of delivery (up to 42 weeks' gestation)Population: Participants who had delivery data are included in the analysis.
A third degree tear is a tear or laceration through the perineal muscles and the anal sphincter. A fourth degree tear goes through the anal sphincter all the way to the anal canal or rectum. This outcome was assessed in pregnant participants.
Outcome measures
| Measure |
Fasting Before Gestational Diabetes Screen
n=96 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
|
Fed Before Gestational Diabetes Screen
n=96 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
|
|---|---|---|
|
Number of Participants Complicated by Third or Fourth Degree Perineal Laceration
|
2 Participants
|
4 Participants
|
SECONDARY outcome
Timeframe: Up to 6 weeks after deliveryPopulation: Participants who had delivery data are included in the analysis.
This outcome was assessed in pregnant participants after delivery.
Outcome measures
| Measure |
Fasting Before Gestational Diabetes Screen
n=96 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
|
Fed Before Gestational Diabetes Screen
n=96 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
|
|---|---|---|
|
Number of Participants With Post-partum Hemorrhage
|
16 Participants
|
10 Participants
|
SECONDARY outcome
Timeframe: From time of GDM screen up to 6 weeks after deliveryPopulation: Participants who had delivery data are included in the analysis.
This outcome was assessed in pregnant participants.
Outcome measures
| Measure |
Fasting Before Gestational Diabetes Screen
n=96 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
|
Fed Before Gestational Diabetes Screen
n=96 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
|
|---|---|---|
|
Number of Participants Diagnosed With a Hypertensive Disorder of Pregnancy
|
22 Participants
|
15 Participants
|
SECONDARY outcome
Timeframe: Up to 1 week after deliveryPopulation: Participants who had delivery data are included in the analysis.
Average number of days admitted in the hospital after delivery up to discharge
Outcome measures
| Measure |
Fasting Before Gestational Diabetes Screen
n=96 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
|
Fed Before Gestational Diabetes Screen
n=96 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
|
|---|---|---|
|
Length of Postnatal Stay From Delivery to Discharge
|
2.3 days
Standard Deviation 0.9
|
2.4 days
Standard Deviation 1.1
|
SECONDARY outcome
Timeframe: From initial hospital discharge up to 6 weeks post-partumPopulation: Participants who had delivery data are included in the analysis.
This outcome was assessed in pregnant participants post-delivery.
Outcome measures
| Measure |
Fasting Before Gestational Diabetes Screen
n=96 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
|
Fed Before Gestational Diabetes Screen
n=96 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
|
|---|---|---|
|
Number of Participants Who Had a Postpartum Readmission
|
4 Participants
|
6 Participants
|
SECONDARY outcome
Timeframe: From time of delivery up to 6 weeks post-partumPopulation: Participants who had delivery data are included in the analysis.
This outcome was assessed in pregnant participants after delivery.
Outcome measures
| Measure |
Fasting Before Gestational Diabetes Screen
n=96 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
|
Fed Before Gestational Diabetes Screen
n=96 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
|
|---|---|---|
|
Number of Participants With Type 2 Diabetes Mellitus Diagnosis Post-partum
|
1 Participants
|
0 Participants
|
SECONDARY outcome
Timeframe: Day of delivery (Within approximately 2 hours after delivery)Population: Participants with a live birth are included in the analysis.
Outcome measures
| Measure |
Fasting Before Gestational Diabetes Screen
n=96 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
|
Fed Before Gestational Diabetes Screen
n=95 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
|
|---|---|---|
|
Mean Neonatal Birthweight
|
3231 grams
Standard Deviation 631
|
3268 grams
Standard Deviation 458
|
SECONDARY outcome
Timeframe: Day of delivery (Within approximately 2 hours after delivery)Population: Participants with a live birth are included in the analysis.
Outcome measures
| Measure |
Fasting Before Gestational Diabetes Screen
n=96 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
|
Fed Before Gestational Diabetes Screen
n=95 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
|
|---|---|---|
|
Number of Neonates With Birth Weight More Than 4000 Grams
|
6 neonates
|
6 neonates
|
SECONDARY outcome
Timeframe: Day of delivery (Within approximately 2 hours after delivery)Population: Participants with a live birth are included in the analysis.
LGA refers to neonatal birth weight larger than the 90th percentile for gestational age.
Outcome measures
| Measure |
Fasting Before Gestational Diabetes Screen
n=96 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
|
Fed Before Gestational Diabetes Screen
n=95 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
|
|---|---|---|
|
Number of Neonates Considered Large for Gestational Age (LGA)
|
6 neonates
|
7 neonates
|
SECONDARY outcome
Timeframe: Day of delivery (Within approximately 2 hours after delivery)Population: Participants with a live birth are included in the analysis.
SGA are infants whose weight is \< the 10th percentile for gestational age.
Outcome measures
| Measure |
Fasting Before Gestational Diabetes Screen
n=96 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
|
Fed Before Gestational Diabetes Screen
n=95 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
|
|---|---|---|
|
Number of Neonates Considered Small for Gestational Age (SGA)
|
6 neonates
|
9 neonates
|
SECONDARY outcome
Timeframe: Up to 28 days after deliveryPopulation: Participants with a live birth are included in the analysis.
Outcome measures
| Measure |
Fasting Before Gestational Diabetes Screen
n=96 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
|
Fed Before Gestational Diabetes Screen
n=95 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
|
|---|---|---|
|
Number of Neonates Admitted to the Neonatal Intensive Care Unit (NICU)
|
4 neonates
|
7 neonates
|
SECONDARY outcome
Timeframe: Up to 28 days after deliveryPopulation: Participants with a live birth are included in the analysis.
Outcome measures
| Measure |
Fasting Before Gestational Diabetes Screen
n=96 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
|
Fed Before Gestational Diabetes Screen
n=95 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
|
|---|---|---|
|
Number of Neonates With Hyperbilirubinemia
|
7 neonates
|
9 neonates
|
SECONDARY outcome
Timeframe: Up to 28 days after deliveryPopulation: Participants with a live birth are included in the analysis.
Outcome measures
| Measure |
Fasting Before Gestational Diabetes Screen
n=96 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
|
Fed Before Gestational Diabetes Screen
n=95 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
|
|---|---|---|
|
Number of Neonates With Hypoglycemia
|
9 neonates
|
5 neonates
|
SECONDARY outcome
Timeframe: Up to 28 days after deliveryPopulation: Participants with a live birth are included in the analysis.
Outcome measures
| Measure |
Fasting Before Gestational Diabetes Screen
n=96 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
|
Fed Before Gestational Diabetes Screen
n=95 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
|
|---|---|---|
|
Number of Neonates Diagnosed With Respiratory Distress Syndrome
|
7 neonates
|
7 neonates
|
SECONDARY outcome
Timeframe: Up to 28 days after deliveryPopulation: Participants with breast feeding data are included in the analysis
Outcome measures
| Measure |
Fasting Before Gestational Diabetes Screen
n=86 Participants
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
|
Fed Before Gestational Diabetes Screen
n=88 Participants
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
|
|---|---|---|
|
Number of Neonates Exclusively Breastfeeding at Time of Hospital Discharge
|
62 neonates
|
59 neonates
|
Adverse Events
Fasting Before Gestational Diabetes Screen
Fed Before Gestational Diabetes Screen
Serious adverse events
| Measure |
Fasting Before Gestational Diabetes Screen
n=100 participants at risk
Fasting for at least 6 hours prior to the 1-hour gestational diabetes screen.
|
Fed Before Gestational Diabetes Screen
n=100 participants at risk
Liberal per oral intake within 2 hours of the 1-hour gestational diabetes screen.
|
|---|---|---|
|
Pregnancy, puerperium and perinatal conditions
Intrauterine fetal demise
|
1.0%
1/100 • Up to 22 weeks (from 24 weeks gestation up to 6 weeks post-partum)
|
0.00%
0/100 • Up to 22 weeks (from 24 weeks gestation up to 6 weeks post-partum)
|
|
Congenital, familial and genetic disorders
Congenital anomaly
|
1.0%
1/100 • Up to 22 weeks (from 24 weeks gestation up to 6 weeks post-partum)
|
0.00%
0/100 • Up to 22 weeks (from 24 weeks gestation up to 6 weeks post-partum)
|
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place